Burden of Palliative Care in a Public General Hospital Setting

ABSTRACT Objective: The number of palliative care patients in Trinidad and Tobago is unknown. The purpose of this study is to estimate the prevalence of palliative care patients on a public general medical ward. Methods: A retrospective cross-sectional study was undertaken to collect information on patients' diagnoses, symptoms and Palliative Performance Scale (PPS) scores. Patients who would benefit from palliative care services and satisfied inclusion criteria were referred to as palliative-care-appropriate patients. Results: The one-month prevalence of palliative-care-appropriate patients was found to be 23.47% on an acute medical ward of a public hospital. Most of these patients had diagnoses that were either neurologic or cardiac in nature. Pain (46.8%) and dyspnoea (51.1%) were the most common symptoms documented for palliative-care-appropriate patients. Seven (14.95%) palliative-care-appropriate patients died while in hospital. Conclusion: There is a significant palliative care burden in this pilot study as evidenced by the high prevalence of palliative-care-appropriate patients on a general medicine ward. A larger prospective study should be undertaken to elucidate the number of patients who could benefit from hospice and palliative care services. Palliative performance scale scores may be considered for more widespread use in the Caribbean.

A Retrospective Observational Study to Explore Trajectories of Hematologic Data and Palliative Performance Scale Scores in the Last 12 Weeks among Patients with Terminal-stage Cancer

Objective: To explore the trajectories of hematologic data and palliative performance scale (PPS) scores among patients with terminal-stage cancer. Method: This was a retrospective observational study. We recruited all adult patients with solid cancer who received care from palliative care specialists and died in Komaki City Hospital between January and December 2016. Among these patients, we extracted hematologic data from the last 12 weeks and when 2 weeks passed since the last anti-cancer treatment, and PPS scores on the day of the hematologic tests. We calculated the means of weekly hematologic data and PPS scores, and explored their trajectories. Results: We recruited 204 patients (mean age, 70.9 years; women, 44.1%) and acquired 1157 hematological datasets. Albumin and C-reactive protein levels gradually decreased from 12 weeks and increased from 5 weeks, respectively, before death. White blood cell and lymphocyte counts respectively increased and decreased from 5 weeks. Creatinine and bilirubin levels rapidly increased from 3 weeks. Potassium levels increased from 1 week. PPS scores decreased from 4 weeks before death. Discussion: Deteriorations in nutrition or inflammatory status and white blood cell counts could antedate deterioration in PPS scores, and deterioration of visceral data and PPS scores could indicate prognosis on a weekly basis.